Fc gamma RIIB/C / CD32b/c

Fc gamma RIIB/C / CD32b/c

Fc gamma RIIB/C / CD32b/c Overview

Molecule Name
Low affinity immunoglobulin gamma Fc region receptor II-b
Synonyms
FCGR2B,C,CD32b,c,FcRII-b,c,Fc-gamma RII-b,c,Fc-gamma-RIIb,c,CD32,FCG2,IGFR2,CDw32
Drug Development Progress
Drugs in Clinical Trials5
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
IgG Fc Receptor II-C,Fc Fragment Of IgG, Low Affinity IIb, Receptor (CD32),Fc Gamma Receptor IIb,IgG Fc Receptor II-B,Fc-Gamma RII-B,FcRII-B,CDw32,FCG2,Low Affinity Immunoglobulin Gamma Fc Region Receptor II-B,Fc Fragment Of IgG, Low Affinity II, Receptor For (CD32),Fc Gamma RIIb,CD32 Antigen,CD32B,FCGR2,Fc-gamma-RIIb,FCGR2B,IGFR2,CD32,Fc Fragment Of IgG Receptor IIb,Fc-Gamma RII-C,Low Affinity Immunoglobulin Gamma Fc Region Receptor II-C,Fc Fragment Of IgG, Low Affinity IIb, Receptor For (CD32),FcRII-C,FCGR2C,Fc-Gamma-RIIc
Background
Receptors for the Fc region of IgG (Fc γ R) are members of the Ig superfamily that function in the activation or inhibition of immune responses. Three classes of human Fc γ Rs: RI (CD64), RII (CD32), and RIII (CD16), which generate multiple isoforms, are recognized. There are three genes for human Fcγ RII /CD32 (A, B, and C) and one for mouse Fcγ RII B (CD32B). CD32 is a low affinity receptor for IgG. Low affinity immunoglobulin gamma Fc region receptor II-b (FCGR2B) is also known as CD32b, FCG2, IGFR2. CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target for monoclonal antibody therapy for malignancies.

Fc gamma RIIB/C / CD32b/c Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ObexelimabXmAb-5871; AMG-729Phase 3 ClinicalXencor Inc
Anemia, Hemolytic, Autoimmune; Immunoglobulin G4-Related Disease; Lupus Erythematosus, Systemic; Multiple Sclerosis
Details
BI-12066G-11; BI-1206Phase 2 ClinicalBioinvent International Ab
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Solid tumours; Waldenstrom Macroglobulinemia
Details
BI-1607BI-1607Phase 2 ClinicalBioinvent International Ab
Adenocarcinoma; Breast Neoplasms; Esophageal Neoplasms; Melanoma; Metastatic breast cancer; Skin Melanoma; Solid tumours; Stomach Neoplasms; Uveal melanoma
Details
NVG-2089NVG-2089Phase 2 ClinicalNuvig Therapeutics Inc
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Purpura, Thrombocytopenic, Idiopathic
Details
S-4321S-4321Phase 1 ClinicalSeismic Therapeutics Inc
Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; Dermatitis, Atopic; Immune System Diseases; Lupus Erythematosus, Cutaneous; Psoriasis
Details